Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia : Biological Chemistry Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia

Joakim E. Swedberg1 / Simon J. de Veer1 / Jonathan M. Harris1

1Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland 4059, Australia

Corresponding author

Citation Information: Biological Chemistry. Volume 391, Issue 4, Pages 357–374, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/bc.2010.037, February 2010

Publication History

Received:
2009-10-16
Accepted:
2010-01-05
Published Online:
2010-02-24

Abstract

The kallikreins and kallikrein-related peptidases are serine proteases that control a plethora of developmental and homeostatic phenomena, ranging from semen liquefaction to skin desquamation and blood pressure. The diversity of roles played by kallikreins has stimulated considerable interest in these enzymes from the perspective of diagnostics and drug design. Kallikreins already have well-established credentials as targets for therapeutic intervention and there is increasing appreciation of their potential both as biomarkers and as targets for inhibitor design. Here, we explore the current status of naturally occurring kallikrein protease-inhibitor complexes and illustrate how this knowledge can interface with strategies for rational re-engineering of bioscaffolds and design of small-molecule inhibitors.

Keywords: bioscaffold; drug design; inhibitor; phage display; protease positional scanning synthetic combinatorial library; sunflower trypsin inhibitor

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Jingjing Xu, Serena Ambrosini, Emel Tamahkar, Claire Rossi, Karsten Haupt, and Bernadette Tse Sum Bui
Biomacromolecules, 2015
[2]
Vittore Cereda, Vincenzo Formica, Antonello Menghi, Stefania Pellicori, and Mario Roselli
Expert Opinion on Investigational Drugs, 2015, Volume 24, Number 7, Page 929
[3]
Ioannis Prassas, Azza Eissa, Gennadiy Poda, and Eleftherios P. Diamandis
Nature Reviews Drug Discovery, 2015, Volume 14, Number 3, Page 183
[4]
Shelley E Ackerman, Nicolas V Currier, Jamie M Bergen, and Jennifer R Cochran
Expert Review of Proteomics, 2014, Volume 11, Number 5, Page 561
[5]
Ruth Anna Fuhrman-Luck, Munasinghage Lakmali Silva, Ying Dong, Helen Irving-Rodgers, Thomas Stoll, Marcus Lachlan Hastie, Daniela Loessner, Jeffrey John Gorman, and Judith Ann Clements
PROTEOMICS - Clinical Applications, 2014, Volume 8, Number 5-6, Page 403
[6]
Konstantinos Mavridis, Margaritis Avgeris, and Andreas Scorilas
Expert Opinion on Therapeutic Targets, 2014, Volume 18, Number 4, Page 365
[7]
Simon J. de Veer, Svetlana S. Ukolova, Christopher A. Munro, Joakim E. Swedberg, Ashley M. Buckle, and Jonathan M. Harris
Biopolymers, 2013, Volume 100, Number 5, Page 510
[8]
Stephan Schultz, Anja Saalbach, John T. Heiker, Rene Meier, Tristan Zellmann, Jan C. Simon, and Annette G. Beck‑Sickinger
Biochemical Journal, 2013, Volume 452, Number 2, Page 271
[9]
J. Fischer and U. Meyer-Hoffert
Thrombosis and Haemostasis, 2013, Volume 110, Number 3, Page 442
[10]
Giuseppe Caliendo, Vincenzo Santagada, Elisa Perissutti, Beatrice Severino, Ferdinando Fiorino, Francesco Frecentese, and Luiz Juliano
Journal of Medicinal Chemistry, 2012, Volume 55, Number 15, Page 6669
[11]
Joakim E. Swedberg and Jonathan M. Harris
ChemBioChem, 2012, Volume 13, Number 3, Page 336
[12]
Simon J. de Veer, Joakim E. Swedberg, Edward A. Parker, and Jonathan M. Harris
Biological Chemistry, 2012, Volume 393, Number 5
[13]
Joakim E. Swedberg and Jonathan M. Harris
Biochemistry, 2011, Volume 50, Number 39, Page 8454
[15]
Peter Goettig, Viktor Magdolen, and Hans Brandstetter
Biochimie, 2010, Volume 92, Number 11, Page 1546

Comments (0)

Please log in or register to comment.